These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 25547417

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synergistic activities of ceftazidime-avibactam in combination with different antibiotics against colistin-nonsusceptible clinical strains of Pseudomonas aeruginosa.
    Mataraci Kara E, Yilmaz M, İstanbullu Tosun A, Özbek Çelik B.
    Infect Dis (Lond); 2020 Sep; 52(9):616-624. PubMed ID: 32427010
    [Abstract] [Full Text] [Related]

  • 3. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO.
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro activity of colistin against multidrug-resistant Pseudomonas aeruginosa isolates from patients in Songklanagarind Hospital, Thailand.
    Tunyapanit W, Pruekprasert P, Laoprasopwattana K, Chelae S.
    Southeast Asian J Trop Med Public Health; 2013 Mar; 44(2):273-80. PubMed ID: 23691637
    [Abstract] [Full Text] [Related]

  • 8. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
    Yasmin F, Akhtar N, Hameed A.
    Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
    [Abstract] [Full Text] [Related]

  • 9. Time-kill effect of levofloxacin on multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: synergism with imipenem and colistin.
    Safarika A, Galani I, Pistiki A, Giamarellos-Bourboulis EJ.
    Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):317-23. PubMed ID: 25192733
    [Abstract] [Full Text] [Related]

  • 10. In vitro activities of colistin, imipenem and ceftazidime against drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in the south of Iran.
    Malekzadegan Y, Abdi A, Heidari H, Moradi M, Rastegar E, Sedigh Ebrahim-Saraie H.
    BMC Res Notes; 2019 May 28; 12(1):301. PubMed ID: 31138309
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo synergy of levofloxacin or amikacin both in combination with ceftazidime against clinical isolates of Pseudomonas aeruginosa.
    Piccoli L, Guerrini M, Felici A, Marchetti F.
    J Chemother; 2005 Aug 28; 17(4):355-60. PubMed ID: 16167512
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
    Tessier F, Quentin C.
    Eur J Clin Microbiol Infect Dis; 1997 Feb 28; 16(2):159-62. PubMed ID: 9105845
    [Abstract] [Full Text] [Related]

  • 15. Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones.
    Montero MM, Domene Ochoa S, López-Causapé C, VanScoy B, Luque S, Sorlí L, Campillo N, Padilla E, Prim N, Segura C, Pomar V, Rivera A, Grau S, Ambrose PG, Oliver A, Horcajada JP.
    J Glob Antimicrob Resist; 2019 Sep 28; 18():37-44. PubMed ID: 31154007
    [Abstract] [Full Text] [Related]

  • 16. In vitro Etest synergy of doripenem with amikacin, colistin, and levofloxacin against Pseudomonas aeruginosa with defined carbapenem resistance mechanisms as determined by the Etest method.
    He W, Kaniga K, Lynch AS, Flamm RK, Davies TA.
    Diagn Microbiol Infect Dis; 2012 Dec 28; 74(4):417-9. PubMed ID: 22995366
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial susceptibility of multidrug-resistant Pseudomonas aeruginosa isolated from drinking water and hospitalized patients in Jordan.
    Tarazi YH, Abu-Basha E, Ismail ZB, Al-Jawasreh SI.
    Acta Trop; 2021 May 28; 217():105859. PubMed ID: 33582141
    [Abstract] [Full Text] [Related]

  • 18. Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ, Kentepozidis N, Antonopoulou A, Plachouras D, Tsaganos T, Giamarellou H.
    Diagn Microbiol Infect Dis; 2005 Feb 28; 51(2):113-7. PubMed ID: 15698716
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synergistic antibiotic combinations for colistin-resistant Klebsiella pneumoniae.
    Kádár B, Kocsis B, Tóth Á, Damjanova I, Szász M, Kristóf K, Nagy K, Szabó D.
    Acta Microbiol Immunol Hung; 2013 Jun 28; 60(2):201-9. PubMed ID: 23827751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.